Publications found:
677
Sort by:
Personalized Oncology & Immunotherapy Market Forecasts to 2034 – Global Analysis By Therapy Type (Immune Checkpoint Inhibitors, CAR-T Cell Therapy, Cancer Vaccines, Monoclonal Antibodies, Targeted Small Molecule Therapy and Other Therapy Types), Biomarker, Cancer Type, Technology, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Personalized Oncology & Immunotherapy Market is accounted for $180 billion in 2026 and is expected to reach $420 billion by 2034 growing at a CAGR of 11% durin...
April 2026
200 pages
Radiation Oncology Market Size, Share & Trends Analysis Report By Treatment (Internal Beam Radiation Therapy, Systemic Targeted Radiation Therapy), By Technology, By Application, By Target Customer (Academic & Research Cancer Centers, Private Oncology Chains), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global radiation oncology market size is expected to reach USD 10.1 billion by 2025, according to a new report by Grand ... CAGR over the forecast period North America held maximum share in global radiation oncology market in 2016. Developed health infrastructure, presence of many multinational players ...
April 2026
150 pages
Global Cancer Supportive Care Drugs Market Size Study and Forecast by Therapeutic Class (ESA (Erythropoiesis Stimulating Agents), G-CSFs (Granulocyte Colony Stimulating Factors), Antiemetics, Bisphosphonates, Opioids, NSAIDs (Non-Steroidal Auto Inflammatory Drugs)), Application (Breast Cancer, Stomach Cancer, Colorectal Cancer, Liver Cancer, Prostate Cancer), Distribution Channel (Drug pharmacies/ Retail pharmacies, Hospital Pharmacies, Online Pharmacies), and Regional Forecasts 2026-2035
US$ 3,750.00
The global cancer supportive care drugs market comprises pharmaceutical products designed to manage the side effects and complications associated with cancer and its treatment. These drugs play a crit...
April 2026
285 pages
Lung Cancer Therapeutics Market Report by Therapy (Targeted Therapy, Immunotherapy, Radiation Therapy, Chemotherapy), Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2026-2034
US$ 3,999.00
The global lung cancer therapeutics market size reached USD 36,081.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 76,308.4 Million by 2034, exhibiting a growth rate (C...
April 2026
137 pages
Testicular Cancer Drugs Market Report by Type of Cancer (Seminoma, Non-Seminoma), Drug Type (Cisplatin, Etoposide, Ifosfamide, Vinblastine, Bleomycin, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2026-2034
US$ 3,999.00
The global testicular cancer drugs market size reached USD 747.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,081.2 Million by 2034, exhibiting a growth rate (CAGR)...
April 2026
146 pages
Immune Checkpoint Inhibitors Market Report by Type (CTLA-4 Inhibitor, PD-1 Inhibitor, PD-L1 Inhibitor), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Lung Cancer, Bladder Cancer, Melanoma, Colorectal Cancer, Hodgkin Lymphoma, and Others), and Region 2026-2034
US$ 3,999.00
The global immune checkpoint inhibitors market size reached USD 56.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 182.4 Billion by 2034, exhibiting a growth rate (CAGR...
April 2026
150 pages
Cancer Cachexia Market Report by Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others), Mode of Action (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel (Hospital Stores, Retail Pharmacy, Online Pharmacy), and Region 2026-2034
US$ 3,999.00
The global cancer cachexia market size reached USD 2.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.74% durin...
April 2026
143 pages
Gastric Cancer Drugs Market Report by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2026-2034
US$ 3,999.00
The global gastric cancer drugs market size reached USD 5.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 14.1 Billion by 2034, exhibiting a growth rate (CAGR) of 10.27...
April 2026
136 pages
Lip Care Products Market Report by Product Type (Non-Medicated, Medicated and Therapeutic, Sun Protection), Distribution Channel (Supermarkets and Hypermarkets, Specialty Retailers, Pharmacies and Drug Stores, Online Stores, and Others), and Region 2026-2034
US$ 3,999.00
The global lip care products market size reached USD 2.64 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.65 Billion by 2034, exhibiting a growth rate (CAGR) of 3.54% d...
April 2026
139 pages
Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 3,999.00
The global prostate cancer treatment market size reached USD 8.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.7 Billion by 2034, exhibiting a growth rate (CAGR) of...
April 2026
138 pages
Retinoblastoma Treatment Market Size, Share, Trends and Forecast by Type, Treatment Type, Type of Staging, Application, and Region, 2026-2034
US$ 3,999.00
The global retinoblastoma treatment market size was valued at USD 3.1 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 4.2 Billion by 2034, exhibiting a CAGR of 3.38% fr...
April 2026
139 pages
Doxorubicin Market Report by Application (Breast Cancer, Ovarian Cancer, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Endometrial Cancer, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Stores, and Others), and Region 2026-2034
US$ 3,999.00
The global doxorubicin market size reached USD 1.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.86% during 20...
April 2026
137 pages
Radiation Oncology Market Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Technology (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy (3D CRT), Volumetric Modulated Arc Therapy (VMAT), Brachytherapy), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, Gynecological Cancer, Cervical Cancer, Penile Cancer, and Others), End User (Hospitals, Cancer Research Institutes, Ambulatory and Radiotherapy Centers), and Region 2026-2034
US$ 3,999.00
The global radiation oncology market size reached USD 9.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.8 Billion by 2034, exhibiting a growth rate (CAGR) of 6.01% d...
April 2026
148 pages
Alpha Emitter Market Size, Share, Trends and Forecast by Type of Radionuclide, Medical Application, End User, and Region, 2026-2034
US$ 3,999.00
The global alpha emitter market size was valued at USD 2,261.0 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 13,625.1 Million by 2034, exhibiting a CAGR of 21.42% fro...
April 2026
144 pages
Lung Cancer Therapeutics: Global Markets
US$ 4,650.00
... for the lung cancer therapeutics market, and information pertaining to leading lung cancer market players, their marketed products, pipeline products and product patent expirations Detailed company profiles of major manufacturers of oncology products, including ...
March 2026
209 pages
Global Temozolomide API Market Growth 2026-2032
US$ 3,660.00
The global Temozolomide API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Temozolomide is a type of chemothe...
March 2026
97 pages
Global Niraparib API Market Growth 2026-2032
US$ 3,660.00
The global Niraparib API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Niraparib API refers to the core acti...
March 2026
93 pages
Global Niraparib Preparations Market Growth 2026-2032
US$ 3,660.00
The global Niraparib Preparations market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Niraparib preparations are o...
March 2026
78 pages
Global Malignancy Photosensitizers Market Growth 2026-2032
US$ 3,660.00
The global Malignancy Photosensitizers market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. photosensitizers are co...
March 2026
95 pages
Global Bexarotene Drugs Market Growth 2026-2032
US$ 3,660.00
The global Bexarotene Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Bexarotene is a synthetic retinoid...
March 2026
99 pages
Global Enzalutamide Tablets Market Growth 2026-2032
US$ 3,660.00
The global Enzalutamide Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Enzalutamide is an active phar...
March 2026
80 pages
Dasatinib Market Size, Share & Trends Analysis Report By Drug Type, (Branded, Generic), By Indication (Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL)), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global dasatinib market size was estimated at USD 5.59 billion in 2025 and is projected to reach USD 7.57 billion by 2033, growing at a CAGR of 4.27% from 2026 to 2033. The global dasatinib market...
March 2026
150 pages
Radioligand Therapeutics in Cancer Treatment: Global Markets
US$ 4,650.00
The global market for radioligand therapeutics in cancer treatment is estimated to grow from $2.6 billion in 2025 to $4.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% f...
February 2026
106 pages
